EGFR and hepatocellular carcinoma: In conformity with Wang et al., who found increased EGFR and AKT activation in HCC cell lines, by forced ADAM17 expression [31], we demonstrated a cisplatin induced EGFR phosphorylation in Igrov-1 and Skov-3 cells.